ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,750Medicare Part D Prescriptions Filled, Including Refills

Rank: 94 out of 1942

$385K Total Retail Price of All Prescriptions

Rank: 248 out of 1942

388 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 388 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

14% of this provider’s 388 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 8,353 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$40 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
FUROSEMIDE 466 452 1 5
SIMVASTATIN 427 366 2 1
LEVOTHYROXINE SODIUM 418 366 3 3
WARFARIN SODIUM 409 332 4 11
CITALOPRAM HBR 318 283 5 15
OMEPRAZOLE 316 305 6 4
HYDROCODONE-ACETAMINOPHEN 260 161 S3 7 12
AMLODIPINE BESYLATE 253 238 8 6
LISINOPRIL 248 212 9 2
METOPROLOL TARTRATE 246 236 10 9
POTASSIUM CHLORIDE 210 206 11 17
LOSARTAN POTASSIUM 195 183 12 18
GABAPENTIN 176 144 13 16
TRAMADOL HCL 168 134 14 19
RANITIDINE HCL 148 105 15 31
ATENOLOL 125 113 16 7
METFORMIN HCL 123 96 17 10
DIGOXIN 113 109 18 40
SERTRALINE HCL 111 71 19 20
HYDROCHLOROTHIAZIDE 105 89 20 8
METOPROLOL SUCCINATE 102 93 21 13
NAMENDA 96 96 22 51
POLYETHYLENE GLYCOL 3350 93 87 23 28
LACTULOSE 89 89 24 120
TAMSULOSIN HCL 86 77 25 29
KLOR-CON 10 83 72 26 102
ATORVASTATIN CALCIUM 79 58 27 14
DONEPEZIL HCL 73 73 28 30
CLOPIDOGREL 72 66 29 55
ALLOPURINOL 64 40 30 26
ALENDRONATE SODIUM 63 51 31 21
AMLODIPINE BESYLATE-BENAZEPRIL 60 60 32 106
ZETIA 60 49 32 75
TRAZODONE HCL 59 40 34 24
SPIRIVA 58 58 35 57
DIOVAN 57 44 36 44
PLAVIX 57 52 36 83
CARVEDILOL 56 54 38 39
GLIPIZIDE ER 56 55 38 80
DILTIAZEM 24HR ER 54 36 40 172
KLOR-CON M20 53 53 41 97
PAROXETINE HCL 51 44 42 50
QUETIAPINE FUMARATE 50 47 43 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 10, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.